Re: Revision to the QTdrugs List
Three new drugs have been added and one removed from the Possible Risk of TdP category.
Two drugs used for androgen deprivation therapy (Bicalutamide and Relugolix) and an antibiotic (Linezolid) have been added to the Possible Risk catagory.
The drug combination, Moexipril and Hydrocholorothiazide was removed from the Possible Risk of TdP category due to labelling changes and a lack of supporting evidence.
Thank you for your interest and continued support of CredibleMeds.
Ray Woosley and the Scientific Review Committee